Nashville-Davidson, Tennessee 2021-10-26 08:27:37 –
Nashville, Tennessee (WTVF) —The FDA’s advisory board will meet on Tuesday to vote on whether to recommend the Pfizer COVID-19 vaccine to infants aged 5 to 11 years.
Immediately, parents must make a major decision on whether to vaccinate their children.
Some doctors say parents should talk to their children about getting shots and how it can potentially protect others around them.
If the FDA Advisory Board approves Pfizer’s child vaccine approval request, the FDA’s decision will continue and the CDC will consider it.
A Pfizer study found that double-dose vaccine therapy was 91% effective in preventing symptomatic infections in children aged 5 to 11 years.
Pfizer has produced a new product that is one-third of the dose. It is chosen not only to be effective, but also to minimize side effects.
Pediatrician Dr. Lisa Kronin has seen some children who were worried about the vaccine better understand what they are and how they work.
Therefore, she suggests teaching children about science and what it means to roll up sleeves for shots.
“I really explain to them that this is what they are doing to protect their loved ones. They can understand the concept and honestly many people are very excited about it. “We do,” said pediatrician Dr. Lisa Kronin.
If all panels approve vaccines for children, they may be vaccinated as early as next Thursday.
Pfizer will put the children’s vaccine in orange vials, so it shouldn’t be confused with adults.
Pediatricians suggest parents talk with child about COVID vaccine Source link Pediatricians suggest parents talk with child about COVID vaccine